Efficacy of favipiravir against influenza virus resistant to both baloxavir and neuraminidase inhibitors.
Maki KisoSeiya YamayoshiYoshihiro KawaokaPublished in: The Journal of antimicrobial chemotherapy (2023)
Our findings indicate that favipiravir should be used to treat patients with suspected baloxavir-resistant virus infection.
Keyphrases